Cullinan Therapeutics (CGEM)'s 30-day implied volatility (IV30) was 85.0% at the close on November 18, 2026, up from 75.7% the day before, against a 52-week range of 42.6% to 148.5%. Its 20-day historical volatility was 93.1%.
Data as of November 18, 2026.